Axa’s Gildan GIL Stock Holding History

Axa’s Portfolio GIL Stock Details GIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,752	Closed	-$355K	–	1088
2023 Q4	$355K	Buy	10,752 +69	+0.6%	+$2.24K	﹤0.01%	975
2023 Q3	$299K	Sell	10,683 -1,287	-11%	-$38.6K	﹤0.01%	983
2023 Q2	$386K	Buy	11,970 +83	+0.7%	+$2.54K	﹤0.01%	972
2023 Q1	$395K	Sell	11,887 -11,209	-49%	-$346K	﹤0.01%	993
2022 Q4	$633K	Buy	23,096 +161	+0.7%	+$4.67K	﹤0.01%	956
2022 Q3	$648K	Sell	22,935 -6,959	-23%	-$208K	﹤0.01%	924
2022 Q2	$860K	Sell	29,894 -16,802	-36%	-$538K	﹤0.01%	899
2022 Q1	$1.75M	Sell	46,696 -1,904	-4%	-$74.7K	0.01%	857
2021 Q4	$2.06M	Sell	48,600 -27,500	-36%	-$1.09M	0.01%	839
2021 Q3	$2.78M	Hold	76,100	–	–	0.01%	798
2021 Q2	$2.81M	Sell	76,100 -345,600	-82%	-$12.1M	0.01%	820
2021 Q1	$12.9M	Buy	+421,700	New	+$12M	0.04%	459
2020 Q2	–	Sell	-34,700	Closed	-$443K	–	1255
2020 Q1	$443K	Sell	34,700 -11,700	-25%	-$282K	﹤0.01%	991
2019 Q4	$1.37M	Sell	46,400 -134,900	-74%	-$3.95M	0.01%	852
2019 Q3	$6.44M	Buy	181,300 +92,900	+105%	+$3.49M	0.03%	577
2019 Q2	$3.42M	Sell	88,400 -25,000	-22%	-$934K	0.01%	748
2019 Q1	$4.08M	Buy	113,400 +1,800	+2%	+$61.6K	0.02%	696
2018 Q4	$3.39M	Buy	111,600 +23,400	+27%	+$723K	0.01%	701
2018 Q3	$2.68M	Hold	88,200	–	–	0.01%	819
2018 Q2	$2.48M	Buy	88,200 +50,000	+131%	+$1.45M	0.01%	804
2018 Q1	$1.1M	Buy	38,200 +20,300	+113%	+$628K	﹤0.01%	981
2017 Q4	$578K	Buy	+17,900	New	+$558K	﹤0.01%	1128
2016 Q3	–	Sell	-1,500	Closed	-$44K	–	1248
2016 Q2	$44K	Sell	1,500 -10,900	-88%	-$325K	﹤0.01%	1301
2016 Q1	$380K	Buy	12,400 +10,900	+727%	+$289K	﹤0.01%	1047
2015 Q4	$42K	Hold	1,500	–	–	﹤0.01%	1312
2015 Q3	$45K	Hold	1,500	–	–	﹤0.01%	1365
2015 Q2	$50K	Buy	+1,500	New	+$48.1K	﹤0.01%	1331
2014 Q2	–	Sell	-800	Closed	-$20K	–	1400
2014 Q1	$20K	Buy	+800	New	+$20.6K	﹤0.01%	1363
2013 Q4	–	Sell	-2,400	Closed	-$56K	–	1402
2013 Q3	$56K	Buy	+2,400	New	+$53.7K	﹤0.01%	1221

Other funds holding GIL

JFL

Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

CCM

Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return

Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

TCAM

Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return

CCMIC

Cardinal Capital Management Inc (Canada) Winnipeg, Manitoba, Canada $4.13B AUM 31.23% 1-Year Est. Return

Axa's GIL Position: Q1 2024 in Review

Axa sold out of Gildan (GIL) in Q1 2024, closing a stake of 10,752 shares — an estimated $355K sold.

Axa first reported a position in GIL in Q3 2013 and held it in 29 quarters. The position peaked at $12.9M in Q1 2021. 288 funds tracked by Wall St. Rank hold GIL as of Q1 2024.

Axa reported no remaining Gildan position as of Q1 2024 after selling out during the quarter.
Axa sold 10,752 Gildan shares in Q1 2024, an estimated $355K.
Axa first reported a position in Gildan in Q3 2013 and held it in 29 quarters.
Axa's Gildan position peaked at $12.9M in Q1 2021.
288 funds tracked by Wall St. Rank held Gildan as of Q1 2024.

Based on Axa's 13F filing for Q1 2024, filed 15 May 2024.